[1]
|
Friedman, S.L. (2003) Liver Fibrosis—From Bench to Bedside. Journal of Hepatology, 38, 38-53. https://doi.org/10.1016/S0168-8278(02)00429-4
|
[2]
|
Haute autorité de santé (2007) Prise en charge des complications chez les malades atteints de cirrhose Recommandations professionnelles. Médecine Thérapeutique, 14, 47-59.
|
[3]
|
Pariente, A. (2018) Cirrhose et complications. Revue du praticien, 68, e135-e147.
|
[4]
|
Cohen-Solal, A., Seghatol, F. and Durand, F. (2007) Cœur et cirrhose hépatique. MT Cardio, 3, 448-452.
|
[5]
|
Seirafi, M. and Spahr, L. (2009) La cardiomyopathie cirrhotique. Revue Médicale Suisse, 5, 1725-1731.
|
[6]
|
Izzy, M., VanWagner, L.B., Lin, G., Altieri, M., Findlay, J.Y., Oh, J.K., et al. (2020) Redefining Cirrhotic Cardiomyopathy for the Modern Era. Hepatology, 71, 334-345. https://doi.org/10.1002/hep.30875
|
[7]
|
Marchetta, S., Altieri, M., Weil-Verhoeven, D., Mouhat, B., Piérard, L. and Thévenot, T. (2021) La cardiomyopathie cirrhotique: De nouvelles approches diagnostiques. Hépato-Gastro & Oncologie Digestive, 28, 584-592.
|
[8]
|
Al-Hamoudi, W.K. (2010) Cardiovascular Changes in Cirrhosis: Pathogenesis and Clinical Implications. The Saudi Journal of Gastroenterology, 16, 145-153. https://doi.org/10.4103/1319-3767.65181
|
[9]
|
Baik, S.K., Fouad, T.R. and Lee, S.S. (2007) Cirrhotic Cardiomyopathy. Orphanet Journal of Rare Diseases, 2, Article No. 15. https://doi.org/10.1186/1750-1172-2-15
|
[10]
|
Guèye, M.N., Louise, B.M., Malick, B., Salamata, D., Aïssé, T.M., Ambdil, H., et al. (2018) Anomalies electrocardiographiques et echocardiographiques au cours de la cirrhose virale b: A propos de 60 cas au service d’hepato-gastroenterologie de l’Hopital Aristide Le Dantec de Dakar (HALD). The Pan African Medical Journal, 30, Article 169. https://doi.org/10.11604/pamj.2018.30.169.12344
|
[11]
|
Mimiesse, J.F., Marlyse, N.M., Clausina, A.A., Arnaud, M.O., Ollandzobo Lucie, A.I., Bossali, F., et al. (2020) Evolutionary and Pronostic Aspects of Cirrhosis at the University Hospital of Brazzaville (Congo). Open Journal of Gastroenterology, 10, 23-29. https://doi.org/10.4236/ojgas.2020.101003
|
[12]
|
Ahoui Apendi, C.P., Monamou, J.M., Mongo-Onkouo, A., Itoua-Ngaporo, N., Ngami, R., Mouakosso, M.N., et al. (2019) Mortalité liée aux hépattes B et C dans le service de Gastroentérologie et Médecine interne du CHU de Brazzaville. Annale Des Sciences De La Santé, 19, 85-93.
|
[13]
|
Serhier, Z., Bendahhou, K., Abdelaziz, A.B. and Othmani, M.B. (2020) Methodological Sheet n°1: How to Calculate the Size of a Sample for an Observational Study? La Tunisie Médicale, 98, 1-7.
|
[14]
|
Balde, J., Rao, N.K., Ballala, K., Samanth, J., Shetty, K.R., Patil, N., et al. (2016) Echocardiographic Abnormalities in Cirrhosis & Their Correlation with Severity of Cirrhosis Using Child-Pugh Score among Patients in a Tertiary Care Hospital. Indian Journal of Medical Research, 144, 935-937. https://doi.org/10.4103/ijmr.IJMR_1486_15
|
[15]
|
Yap, E.M.L., Supe, M.G.S. and Yu, I.I. (2018) Cardiac Profile of Filipino Patients with Liver Cirrhosis: A 10-Year Study. Cardiology Research, 9, 358-363. https://doi.org/10.14740/cr804
|
[16]
|
Møller, S. and Henriksen, J.H. (2009) Cardiovascular Complications of Cirrhosis. Postgraduate Medical Journal, 85, 44-54.
|
[17]
|
Abd-El-Aziz, T.A., Abdou, M., Fathy, A. and Wafaie, M. (2010) Evaluation of Cardiac Function in Patients with Liver Cirrhosis. Internal Medicine, 49, 2547-2552. https://doi.org/10.2169/internalmedicine.49.3520
|
[18]
|
Weil, D., André, M., Cervoni, J., Di Martino, V., Moreau, R. and Thévenot, T. (2022) Utilisation de l’albumine au cours de la cirrhose décompensée: Vers de nouveaux concepts. Hépato-Gastro & Oncologie Digestive, 29, 478-487. https://doi.org/10.1684/hpg.2022.2360
|
[19]
|
Bhardwaj, A., Joshi, S., Sharma, R., Bhardwaj, S., Agrawal, R. and Gupta, N. (2020) QTc Prolongation in Patients of Cirrhosis and Its Relation with Disease Severity: An Observational Study from a Rural Teaching Hospital. Journal of Family Medicine and Primary Care, 9, 3020-3024. https://doi.org/10.4103/jfmpc.jfmpc_341_20
|
[20]
|
Genovesi, S., Prata Pizzala, D.M., Pozzi, M., Ratti, L., Milanese, M., Pieruzzi, F., et al. (2009) QT Interval Prolongation and Decreased Heart Rate Variability in Cirrhotic Patients: Relevance of Hepatic Venous Pressure Gradient and Serum Calcium. Clinical Science, 116, 851-859. https://doi.org/10.1042/CS20080325
|
[21]
|
Tint, D., Radoi, M., Coman, F., Zayarache, C. and Rosca, E. (2002) Les atteintes cardiaques dans la cirrhose hépatique—Corrélations avec l’étiologie. La Revue de Médecine Interne, 23, 690s. https://doi.org/10.1016/S0248-8663(02)80673-7
|
[22]
|
Brondex, A., Arlès, F., Lipovac, A.S., Richecoeur, M. and Bronstein, J.A. (2012) Cardiomyopathie cirrhotique: Une entité spécifique. Annales de Cardiologie et d’Angéiologie, 61, 99-104. https://doi.org/10.1016/j.ancard.2011.07.004
|
[23]
|
Billey, C., Billet, S., Robic, M.A., Cognet, T., Guillaume, M., Vinel, J.P., et al. (2019) A Prospective Study Identifying Predictive Factors of Cardiac Decompensation after Transjugular Intrahepatic Portosystemic Shunt: The Toulouse Algorithm. Hepatology, 70, 1928-1941. https://doi.org/10.1002/hep.30934
|
[24]
|
Park, J., Kim, G., Kim, H., Lee, J., Lee, Y.B., Jin, S.M., et al. (2021) The Association of Hepatic Steatosis and Fibrosis with Heart Failure and Mortality. Cardiovascular Diabetology, 20, Article No. 197. https://doi.org/10.1186/s12933-021-01374-8
|
[25]
|
Cesari, M., Frigo, A.C., Tonon, M. and Angeli, P. (2018) Cardiovascular Predictors of Death in Patients with Cirrhosis. Hepatology, 68, 215-223. https://doi.org/10.1002/hep.29520
|